logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Seasonal Affective Disorder

    Medications for Seasonal Affective Disorder

    FiltersReset Filters
    11 results

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Sun Pharmaceutical Industries, Inc.
      Usage: Bupropion hydrochloride extended-release tablets are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established in multiple controlled trials for both conditions, as defined by the DSM.

    • bupropion hydrochloride

      (Bupropion Hydrochloride)
      Actavis Pharma, Inc.
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was demonstrated in multiple controlled trials for both indications.

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Granules Pharmaceuticals Inc.
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in seasonal affective disorder (SAD), as established through controlled clinical trials.

    • bupropion hydrochloride

      (Bupropion Hydrochloride)
      Actavis Pharma, Inc.
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy is supported by controlled clinical trials for both conditions.

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      BluePoint Laboratories
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and for preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy has been demonstrated in multiple controlled trials for both indications.

    • bupropion hydrochloride

      (Bupropion Hydrochloride)
      Lupin Pharmaceuticals, Inc.
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in individuals with seasonal affective disorder (SAD), as defined by the DSM. Efficacy was supported by multiple controlled clinical trials.

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Sun Pharmaceutical Industries, Inc.
      Usage: Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through controlled clinical trials for both conditions.

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Vitruvias Therapeutics
      Usage: Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through controlled trials for both conditions.

    • bupropion hydrochloride

      (Bupropion Hydrochloride)
      Mullan Phamaceutical Inc.
      Usage: Bupropion hydrochloride extended-release tablets are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy is supported by controlled clinical trials for both indications.

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Lannett Company Inc.
      Usage: Bupropion hydrochloride extended-release tablets are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Its efficacy is supported by controlled trials in both acute and maintenance treatment settings.